These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 25695283)

  • 1. Adenovirus-mediated LRIG1 expression enhances the chemosensitivity of bladder cancer cells to cisplatin.
    Yan Z; Jiang J; Li F; Yang W; Xie G; Zhou C; Xia S; Cheng Y
    Oncol Rep; 2015 Apr; 33(4):1791-8. PubMed ID: 25695283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LRIG1 combined with cisplatin enhances bladder cancer lesions via a novel pathway.
    Li F; Yang W; Guo D; Hu Z; Xu H; Ye Z
    Oncol Rep; 2011 Jun; 25(6):1629-37. PubMed ID: 21431282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LRIG1 enhances cisplatin sensitivity of glioma cell lines.
    Wang X; Xiao Q; Xing X; Tian C; Zhang H; Ye F; Wan F; Wang B; Guo D; Lei T
    Oncol Res; 2012; 20(5-6):205-11. PubMed ID: 23581227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of bladder cancer cell tumorigenicity in an athymic mouse model by adenoviral vector-mediated transfer of LRIG1.
    Li F; Ye ZQ; Guo DS; Yang WM
    Oncol Rep; 2011 Aug; 26(2):439-46. PubMed ID: 21567105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitization of human bladder cancer cells to Fas-mediated cytotoxicity by cis-diamminedichloroplatinum (II).
    Mizutani Y; Yoshida O; Bonavida B
    J Urol; 1998 Aug; 160(2):561-70. PubMed ID: 9679929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restoration of LRIG1 suppresses bladder cancer cell growth by directly targeting EGFR activity.
    Chang L; Shi R; Yang T; Li F; Li G; Guo Y; Lang B; Yang W; Zhuang Q; Xu H
    J Exp Clin Cancer Res; 2013 Dec; 32(1):101. PubMed ID: 24314030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of microRNA-4295 enhances cisplatin-induced gastric cancer cell apoptosis through the EGFR/PI3K/Akt signaling pathway by targeting LRIG1.
    Yan R; Li K; Yuan DW; Wang HN; Zhang Y; Dang CX; Zhu K
    Int J Oncol; 2018 Dec; 53(6):2566-2578. PubMed ID: 30320337
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maspin enhances cisplatin chemosensitivity in bladder cancer T24 and 5637 cells and correlates with prognosis of muscle-invasive bladder cancer patients receiving cisplatin based neoadjuvant chemotherapy.
    Chen J; Wang L; Tang Y; Gong G; Liu L; Chen M; Chen Z; Cui Y; Li C; Cheng X; Qi L; Zu X
    J Exp Clin Cancer Res; 2016 Jan; 35():2. PubMed ID: 26733306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LRIG1 enhances the radiosensitivity of radioresistant human glioblastoma U251 cells via attenuation of the EGFR/Akt signaling pathway.
    Yang JA; Liu BH; Shao LM; Guo ZT; Yang Q; Wu LQ; Ji BW; Zhu XN; Zhang SQ; Li CJ; Chen QX
    Int J Clin Exp Pathol; 2015; 8(4):3580-90. PubMed ID: 26097540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Gene therapy study on bladder cancer with recombinant adenoviral vector carrying LRIG1 gene driven by Survivin promoter].
    Yan ZJ; Cheng Y; Jiang JH; Hu JS; Shi XD
    Zhonghua Wai Ke Za Zhi; 2012 Aug; 50(8):732-6. PubMed ID: 23157908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sensitizing effect of galectin-7 in urothelial cancer to cisplatin through the accumulation of intracellular reactive oxygen species.
    Matsui Y; Ueda S; Watanabe J; Kuwabara I; Ogawa O; Nishiyama H
    Cancer Res; 2007 Feb; 67(3):1212-20. PubMed ID: 17283157
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LRIG1 dictates the chemo-sensitivity of temozolomide (TMZ) in U251 glioblastoma cells via down-regulation of EGFR/topoisomerase-2/Bcl-2.
    Qi XC; Xie DJ; Yan QF; Wang YR; Zhu YX; Qian C; Yang SX
    Biochem Biophys Res Commun; 2013 Aug; 437(4):565-72. PubMed ID: 23850692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenovirus-mediated IL-24 expression enhances the chemosensitivity of multidrug-resistantgastric cancer cells to cisplatin.
    Mao Z; Bian G; Sheng W; He S; Yang J; Dong X
    Oncol Rep; 2013 Nov; 30(5):2288-96. PubMed ID: 23982423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced sensitivity of bladder cancer cells to tumor necrosis factor related apoptosis inducing ligand mediated apoptosis by cisplatin and carboplatin.
    Mizutani Y; Nakao M; Ogawa O; Yoshida O; Bonavida B; Miki T
    J Urol; 2001 Jan; 165(1):263-70. PubMed ID: 11125422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downregulation of leucine-rich repeats and immunoglobulin-like domains 1 by microRNA-20a modulates gastric cancer multidrug resistance.
    Zhou L; Li X; Zhou F; Jin Z; Chen D; Wang P; Zhang S; Zhuge Y; Shang Y; Zou X
    Cancer Sci; 2018 Apr; 109(4):1044-1054. PubMed ID: 29450946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A soluble ectodomain of LRIG1 inhibits cancer cell growth by attenuating basal and ligand-dependent EGFR activity.
    Goldoni S; Iozzo RA; Kay P; Campbell S; McQuillan A; Agnew C; Zhu JX; Keene DR; Reed CC; Iozzo RV
    Oncogene; 2007 Jan; 26(3):368-81. PubMed ID: 16847455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of EGFR and LRIG proteins in oesophageal carcinoma with emphasis on patient survival and cellular chemosensitivity.
    Wu X; Hedman H; Bergqvist M; Bergström S; Henriksson R; Gullbo J; Lennartsson J; Hesselius P; Ekman S
    Acta Oncol; 2012 Jan; 51(1):69-76. PubMed ID: 21417672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MK2206 potentiates cisplatin-induced cytotoxicity and apoptosis through an interaction of inactivated Akt signaling pathway.
    Sun D; Sawada A; Nakashima M; Kobayashi T; Ogawa O; Matsui Y
    Urol Oncol; 2015 Mar; 33(3):111.e17-26. PubMed ID: 25499922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ailanthone inhibits cell growth and migration of cisplatin resistant bladder cancer cells through down-regulation of Nrf2, YAP, and c-Myc expression.
    Daga M; Pizzimenti S; Dianzani C; Cucci MA; Cavalli R; Grattarola M; Ferrara B; Scariot V; Trotta F; Barrera G
    Phytomedicine; 2019 Mar; 56():156-164. PubMed ID: 30668336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcribed ultraconserved region Uc.63+ promotes resistance to cisplatin through regulation of androgen receptor signaling in bladder cancer.
    Sekino Y; Sakamoto N; Ishikawa A; Honma R; Shigematsu Y; Hayashi T; Sentani K; Oue N; Teishima J; Matsubara A; Yasui W
    Oncol Rep; 2019 May; 41(5):3111-3118. PubMed ID: 30864720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.